Managing Low Bioavailability in High-Dose Tablet Formulations
Managing Low Bioavailability in High-Dose Tablet Formulations Strategies to Address Low Bioavailability in High-Dose Tablet Formulations What is Bioavailability and Why is it Challenging in High-Dose Tablets? Bioavailability refers to the extent and rate at which the active pharmaceutical ingredient (API) reaches systemic circulation. In high-dose tablet formulations, bioavailability challenges often arise due to poor…
Read More “Managing Low Bioavailability in High-Dose Tablet Formulations” »